Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Orphazyme A/S (ORPHY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Orphazyme historical data, for real-time data please try another search
0.030 0.000    0.00%
06/07 - Real-time Data. Currency in USD ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.001 - 0.100
Type:  Equity
Market:  United States
Orphazyme 0.030 0.000 0.00%

Orphazyme Company Profile

 
Read the Orphazyme A/S company profile to learn more about the business and the management team. View Orphazyme A/S facts about employee data, company products and services, and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

2

Equity Type

ORD

Orphazyme A/S does not have significant operations. Previously, the company was engaged in the development of therapies for the treatment of neurodegenerative rare diseases. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark.

Contact Information

Address Ole Maaløes Vej 3
Copenhagen, 2200
Denmark
Phone 45 70 70 29 80
Fax -

Top Executives

Name Age Since Title
Jakob Færch Bendtsen 45 2023 Director
Jakob Alsted - 2023 Director
Michael Schlomo Gabriely Hove 53 2023 Independent Chairman
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ORPHA Price Commentary

Write your thoughts about Orphazyme
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
saqtah Del
saqtah Del Mar 11, 2022 14:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
41% loss ? What's happening?
Ikram Ullah
Ikram Ullah Jun 28, 2021 18:20
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Is there anything positive going to happen with ORPH in the cery near future?
Nader Salameh
Nader Salameh Jun 28, 2021 18:20
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I doubt it.. Looks like the short squeeze is over!
Michell Kristensen
Michell Kristensen Jun 17, 2021 16:20
Saved. See Saved Items.
This comment has already been saved in your Saved Items
80% chance that FDA will approve it tonight.
Klaus Nørgård
Klaus Nørgård Jun 17, 2021 16:20
Saved. See Saved Items.
This comment has already been saved in your Saved Items
fda need more data down 74% atm
Aravind Tallam
Aravind Tallam Jun 17, 2021 16:20
Saved. See Saved Items.
This comment has already been saved in your Saved Items
FDA disapproved
Akila Chamika
Akila Chamika Jun 11, 2021 17:30
Saved. See Saved Items.
This comment has already been saved in your Saved Items
again see something going to happen
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email